Cardiometabolic Risks in Polycystic Ovary Syndrome: Long-Term Population-Based Follow-Up Study

    November 2018 in “ Fertility and Sterility
    Samira Behboudi-Gandevani, Fahimeh Ramezani Tehrani, Farhad Hosseinpanah, Davood Khalili, Leila Cheraghi, Hadigheh Kazemijaliseh, Fereidoun Azizi
    Image of study
    TLDR Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.
    In a study involving 1702 women, with 178 diagnosed with polycystic ovary syndrome (PCOS) and 1524 serving as healthy controls, researchers found that women with PCOS under 40 years of age had a significantly higher risk of developing hypertension (HR 2.08) and metabolic syndrome (HR 1.81) compared to controls, with these risks diminishing after age 40. The risks for central obesity and obesity were also higher in the PCOS group under 40, but not significantly so after this age, and there was no significant difference in the risk of dyslipidemia between the two groups at any age. The study concluded that while young women with PCOS are at a higher risk for certain cardiometabolic conditions, these risks may decrease later in life, suggesting that cardiometabolic hazards associated with PCOS could diminish over time.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 3 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  449 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  53 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 6 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Similar Research

    5 / 1000+ results